Ryanodine receptor mutations associated with stress-induced ventricular tachycardia mediate increased calcium release in stimulated cardiomyocytes

Circulation Research

Volumn 93, Issue 6, 2003, Pages 531-540

  George, Christopher H ^a   Higgs, Gemma V ^b   Lai, F Anthony ^b  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b NONE

Author keywords

Cardiomyocytes; Mutations; Ryanodine receptors; Stress; Ventricular tachycardia

Indexed keywords

CAFFEINE; CALCIUM ION; CYCLIC AMP; FK 506 BINDING PROTEIN; FK 506 BINDING PROTEIN 12.6; ISOPRENALINE; PLASMID DNA; RYANODINE RECEPTOR; UNCLASSIFIED DRUG; ADENYLATE CYCLASE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM; CHLOROCRESOL; CRESOL; TACROLIMUS BINDING PROTEIN 1B;

ARTICLE; CALCIUM TRANSPORT; GENE MUTATION; HEART MUSCLE CELL; HEART VENTRICLE TACHYCARDIA; HUMAN; HUMAN CELL; PHENOTYPE; PRIORITY JOURNAL; SARCOPLASMIC RETICULUM; STRESS; TACHYCARDIA; CELL LINE; DRUG EFFECT; GENETICS; METABOLISM; MUTATION;

ADENYLATE CYCLASE; ADRENERGIC BETA-AGONISTS; CAFFEINE; CALCIUM; CELL LINE; CRESOLS; HUMANS; ISOPROTERENOL; MUTATION; MYOCYTES, CARDIAC; PHENOTYPE; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; STRESS; TACHYCARDIA, VENTRICULAR; TACROLIMUS BINDING PROTEINS;

EID: 0141571322     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.0000091335.07574.86     Document Type: Article

References (26)

1. Bers DM. Cardiac excitation-contraction coupling. Nature. 2002;415:198-205.
2. Marban E. Cardiac channelopathies. Nature. 2002;415:213-218.
3. Keating MT, Sanguinetti MC. Molecular and cellular mechanisms of cardiac arrhythmias. Cell. 2001;104:569-580.
4. Marx SO, Reiken S, Hisamatsu Y, Gaburjakova M, Gaburjakova J, Yang YM, Rosemblit N, Marks AR. Phosphorylation-dependent regulation of ryanodine receptors: a novel role for leucine-isoleucine zippers. J Cell Biol. 2001;154:699-708.
5. Marx SO, Reiken S, Hisamatsu Y, Jayaraman T, Burkhoff D, Rosemblit N, Marks AR. PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts. Cell. 2000;101:365-376.
6. Xin HB, Senbonmatsu T, Cheng DS, Wang YX, Copello JA, Ji GJ, Collier ML, Deng KY, Jeyakumar LH, Magnuson MA, Inagami T, Kotlikoff MI, Fleischer S. Oestrogen protects FKBP12.6 null mice from cardiac hypertrophy. Nature. 2002;416:334-337.
7. Zhao L, Sebkhi A, Nunez DJR, Long L, Haley CS, Szpirer J, Szpirer C, Williams AJ, Wilkins MR. Right ventricular hypertrophy secondary to pulmonary hypertension is linked to rat chromosome 17: evaluation of cardiac ryanodine Ryr2 receptor as a candidate. Circulation. 2001;103:442-447.
8. Marks AR, Priori S, Memmi M, Kontula K, Laitinen PJ. Involvement of the cardiac ryanodine receptor / calcium release channel in catecholaminergic polymorphic ventricular tachycardia. J Cell Physiol. 2002;190:1-6.
9. Laitinen PJ, Brown KM, Piippo K, Swan H, Devaney JM, Brahmbhatt B, Donarum EA, Marino M, Tiso N, Viittasalo M, Toivonen L, Stephan DA, Kontula K. Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia. Circulation. 2001;103:485-490.
10. Priori SG, Napolitano C, Tiso N, Memmi M, Vignati G, Bloise R, Sorrentino V, Danieli GA. Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia. Circulation. 2001;103:196-200.
11. Tiso N, Stephan DA, Nava A, Bagattin A, Devaney JM, Stanchi F, Larderet G, Brahmbhatt B, Brown K, Bauce B, Muriago M, Basso C, Thiene G, Danieli GA, Rampazzo A. Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2). Hum Mol Genet. 2001;10:189-194.
12. Priori SG, Napolitano C, Memmi M, Colombi B, Drago F, Gasparini M, DeSimeone L, Coltorti F, Bloise R, Keegan R, Cruz Filho FES, Vignati G, Benetar A, DeLogu A. Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. Circulation. 2002;106:69-74.
13. McCarthy TV, Quane KA, Lynch PJ. Ryanodine receptor mutations in malignant hyperthermia and central core disease. Hum Mutat. 2000;15:410-417.
14. George CH, Sorathia R, Bertrand BMA, Lai FA. In situ modulation of the human cardiac ryanodine receptor (hRyR2) by FKBP12.6. Biochem J. 2003;370:579-589.
15. Claycomb WC, Lanson NA, Stallworth BS, Egeland DB, Delcarpio JB, Bahinski A, Izzo NJ. HL-1 cells: a cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte. Proc Natl Acad Sci U S A. 1998;95:2979-2984.
16. George CH, Higgs GV, Mackrill JJ, Lai FA. Dysregulated ryanodine receptors mediate cellular toxicity: restoration of normal phenotype by FKBP12.6. J Biol Chem. 2003;278:28856-28864.
17. Yano M, Kobayashi S, Kohno M, Doi M, Tokuhisa T, Okuda S, Suetsugu M, Hisoaka T, Obayashi M, Ohkusa T, Kohno M, Matsuzaki M. FKBP12.6-mediated stabilization of calcium release channel (ryanodine receptor) as a novel therapeutic strategy against heart failure. Circulation. 2003;107:477-484.
18. 2+ sparks in mouse ventricular myocytes. Circ Res. 2002;90:309-316.
19. 2+ release, but normal ryanodine receptors, in canine and human heart failure. Circ Res, 2002;91:1015-1022.
20. 2+ release channel (ryanodine receptor) mutant associated with ventricular tachycardia and sudden death. Circ Res. 2002;91:218-225.
21. Doi M, Yano M, Kobayashi S, Kohno M, Tokuhisa T, Okuda S, Suetsugu M, Hisamatsu Y, Ohkusa T, Kohno M, Matsuzaki M. Propranolol prevents the development of heart failure by restoring FKBP12.6 mediated stabilization of ryanodine receptor. Circulation. 2002;105:1374-1379.
22. Tiso N, Salamon M, Bagattin A, Danieli GA, Argenton F, Bortolussi M. The binding of the RyR calcium channel to its gating protein FKBP12.6 is oppositely affected by ARVD2 and VTSIP mutations. Biochem Biophys Res Commun. 2002;299:594-598.
23. Wehrens XHT, Lehnart SE, Huang F, Vest JA, Reiken SR, Mohler PJ, Sun J, Guatimosim S, Song LS, Rosemblit N, D'Armiento JM, Napolitano C, Memmi M, Priori SG, Lederer WJ, Marks AR, FKBP12.6 deficiency and defective calcium release channel (ryanodine receptor) function linked to exercise-induced sudden cardiac death. Cell. 2003;113:829-840.
24. Moroni A, Barbuti A, Altomare C, Viscomi C, Morgan J, Baruscotti M, DiFranscesco D. Kinetic and ionic properties of the human HCN2 pacemaker channel. Pflugers Arch. 2000;439:618-626.
25. Lahat H, Pras E, Olender T, Avadan N, Ben-Asher E, Man O, Levy-Nissenbaum E, Khoury A, Lorber A, Goldman B, Lancet D, Eldar M. A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in bedouin families from Israel. Am J Hum Genet. 2001;69:1378-1384.
26. i2. J Clin Invest. 1998;101:2862-2868.